Renaissance Technologies LLC Raises Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Renaissance Technologies LLC lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 373,802 shares of the company's stock after purchasing an additional 15,100 shares during the period. Renaissance Technologies LLC owned 0.75% of Prestige Consumer Healthcare worth $25,736,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Principal Securities Inc. acquired a new stake in Prestige Consumer Healthcare during the fourth quarter worth about $29,000. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $222,000. Quadrant Capital Group LLC lifted its holdings in Prestige Consumer Healthcare by 29.3% in the fourth quarter. Quadrant Capital Group LLC now owns 1,660 shares of the company's stock valued at $102,000 after acquiring an additional 376 shares during the last quarter. Norges Bank purchased a new position in Prestige Consumer Healthcare in the fourth quarter worth approximately $27,739,000. Finally, UBS Group AG increased its stake in Prestige Consumer Healthcare by 377.6% during the fourth quarter. UBS Group AG now owns 131,382 shares of the company's stock worth $8,043,000 after acquiring an additional 103,872 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Trading Down 1.2 %

Prestige Consumer Healthcare stock traded down $0.89 during trading on Friday, hitting $73.03. The company had a trading volume of 866,024 shares, compared to its average volume of 248,976. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The company's 50 day simple moving average is $71.16 and its 200-day simple moving average is $69.67. Prestige Consumer Healthcare Inc. has a 1-year low of $56.34 and a 1-year high of $75.80. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of 17.73, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the previous year, the business earned $1.06 EPS. The company's quarterly revenue was down 4.4% compared to the same quarter last year. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, DA Davidson upped their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Wednesday, August 28th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $98.75.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.